RNA sequencing of the remaining cancer cells after low-efficiency target cell killing revealed that GLI Pathogenesis Related 1 (GLIPR1) was up-regulated and high expression of GLIPR1 decreased survival rate of stomach adenocarcinoma (STAD) patients. Here, GLIPR1 is linked to gastric adenocarcinoma.